TRIDENT PHARMACEUTICALS INC has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1999. It filed its patents most often in United States, Japan and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are HUNAN WARRANT PHARMACEUTICAL CO LTD, BIOINCEPT LLC and RIGSHOSPITALET.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Japan | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Machines | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Peptides | |
#5 | Unspecified technologies | |
#6 | Climate change adaptation technologies | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Williams Neil Andrew | 13 |
#2 | Hirst Timothy Raymond | 13 |
#3 | Bienenstock John | 9 |
#4 | Nashar Toufic Osman | 3 |
#5 | Wilson Andrew Douglas | 1 |
#6 | Bird Lucy Amber | 1 |
#7 | Morgan Andrew | 1 |
Publication | Filing date | Title |
---|---|---|
US2006083751A1 | Methods for the prevention against or treatment of diabetes with ETXB and/or insulin | |
US7914791B1 | Vaccine | |
US7208155B1 | Agent for treating allergic or hypersensitivity condition |